ArticleInternational journal of hematology2020

Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.

Ang Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.